Abstract
Background: Among the many researches on cellular uptake and intracellular trafficking pathways of αvβ3-targeted nanomedicines, a large number of studies utilize serum-free medium to evaluate drug effects and cellular mechanisms in vitro whether the medium is serum free or not has not been paid much attention.
Methods: The aim of this study was to assess the impact of serum on αvβ3-mediated endocytosis and intracellular trafficking pathways. cRGDfK conjugated with Alexa Fluor® 555 was used to recognize αvβ3 integrins specifically. Transferrin-Alexa Fluor® 488 conjugates were selected as the intracellular trafficking pathway markers by real-time confocal analysis method using confocal laser-scanning microscope.
Results: The results showed that after internalization, cRGDfK showed perfect colocalization with transferrin (Tfn) when the cells were cultured in serum-free medium, but manifested obvious separation from Tfn to recycle back to the plasma membrane when the cells were cultured in complete medium. cRGDfK travels two quite different pathways under different culture conditions.
Conclusion: We strongly recommended that when the intracellular mechanisms or pharmacodynamics of αvβ3-targeted nanomedicines was investigated, serum free medium or medium with serum should be taken into consideration. We hope this paper will provide helpful suggestions for studies on αvβ3- targeted drug delivery system.
Keywords: Endocytic recycling, αvβ3 integrin, cRGDfK, transferrin, culture condition, real-time confocal analysis, nanomedicine.
Current Pharmaceutical Biotechnology
Title:Serum Free or Not: Two Distinct Recycling Mechanisms Mediated by Alpha v Beta 3 Integrin
Volume: 18 Issue: 8
Author(s): Yanan Cui, Suxin Li, Binlong Chen, Bing He, Lan Yuan, Wenbing Dai, Hua Zhang, Xueqing Wang*Qiang Zhang*
Affiliation:
- School of Pharmaceutical Sciences, Peking University, Beijing 100191,China
- School of Pharmaceutical Sciences, Peking University, Beijing 100191,China
Keywords: Endocytic recycling, αvβ3 integrin, cRGDfK, transferrin, culture condition, real-time confocal analysis, nanomedicine.
Abstract: Background: Among the many researches on cellular uptake and intracellular trafficking pathways of αvβ3-targeted nanomedicines, a large number of studies utilize serum-free medium to evaluate drug effects and cellular mechanisms in vitro whether the medium is serum free or not has not been paid much attention.
Methods: The aim of this study was to assess the impact of serum on αvβ3-mediated endocytosis and intracellular trafficking pathways. cRGDfK conjugated with Alexa Fluor® 555 was used to recognize αvβ3 integrins specifically. Transferrin-Alexa Fluor® 488 conjugates were selected as the intracellular trafficking pathway markers by real-time confocal analysis method using confocal laser-scanning microscope.
Results: The results showed that after internalization, cRGDfK showed perfect colocalization with transferrin (Tfn) when the cells were cultured in serum-free medium, but manifested obvious separation from Tfn to recycle back to the plasma membrane when the cells were cultured in complete medium. cRGDfK travels two quite different pathways under different culture conditions.
Conclusion: We strongly recommended that when the intracellular mechanisms or pharmacodynamics of αvβ3-targeted nanomedicines was investigated, serum free medium or medium with serum should be taken into consideration. We hope this paper will provide helpful suggestions for studies on αvβ3- targeted drug delivery system.
Export Options
About this article
Cite this article as:
Cui Yanan , Li Suxin , Chen Binlong, He Bing , Yuan Lan, Dai Wenbing , Zhang Hua , Wang Xueqing *, Zhang Qiang*, Serum Free or Not: Two Distinct Recycling Mechanisms Mediated by Alpha v Beta 3 Integrin, Current Pharmaceutical Biotechnology 2017; 18 (8) . https://dx.doi.org/10.2174/1389201018666171004150050
DOI https://dx.doi.org/10.2174/1389201018666171004150050 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Purification and Characterization of a Lectin of the Swartzieae Legume Taxa
Protein & Peptide Letters Nanoparticles in Biomedicine: New Insights from Plant Viruses
Current Medicinal Chemistry Baseline Levels of Interleukine-6, Tumor-Necrosis Factor-Alpha and C-Reactive Protein in Treatment Naive Human Immunodeficiency Virus Infected Patients-A Study from a Tertiary-Care Hospital in Eastern India
Current Biomarkers (Discontinued) Updates of mTOR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry CD6 as a Cell Surface Receptor and As a Target for Regulating Immune Responses
Current Drug Targets A 1536-Well Fluorescence Polarization Assay to Screen for Modulators of the MUSASHI Family of RNA-Binding Proteins
Combinatorial Chemistry & High Throughput Screening The Recent Development of Farnesyltransferase Inhibitors as Anticancer and Antimalarial Agents
Mini-Reviews in Medicinal Chemistry Stem Cell-Derived Microvesicles: A Cell Free Therapy Approach to the Regenerative Medicine
Current Biotechnology Biomolecular Targets for Platinum Antitumor Drugs
Mini-Reviews in Medicinal Chemistry High Dose Immunoglobulin (IVIG) May Reduce the Incidence of Langerhans Cell Histiocytosis (LCH)-Associated Central Nervous System Involvement
CNS & Neurological Disorders - Drug Targets Preface
Current Cancer Drug Targets Sustained Delivery of Interferons by Micro- and Nanosystems
Recent Patents on Materials Science Carbon Nanofiber Reinforced Polycaprolactone Fibrous Meshes by Electrostatic Co-spinning
Current Nanoscience Drug Metabolism and Pharmacokinetics in Support of Drug Design
Current Pharmaceutical Design Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension
Current Cancer Drug Targets Pathogenic Genes Selection Model of Genetic Disease based on Network Motifs Slicing Feedback
Current Proteomics Update on the Use of Biologics in Lupus
Current Pharmaceutical Biotechnology Matrix Metalloproteinase Dependent Cleavage of Cell Adhesion Molecules in the Pathogenesis of CNS Dysfunction with HIV and Methamphetamine
Current HIV Research Genome Scale Modeling in Systems Biology: Algorithms and Resources
Current Genomics Diet and Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets